Site-specific topoisomerase I-mediated DNA cleavage induced by nogalamycin: A potential role of ligand-induced DNA bending at a distal site

S. P. Sim, D. S. Pilch, Leroy-Fong Liu

研究成果: 雜誌貢獻文章

13 引文 (Scopus)

摘要

Many DNA binding ligands (e.g., nogalamycin, actinomycin D, terbenzimidazoles, indolocarbazoles, nitidine, and coralyne) and various types of DNA lesions (e.g., UV dimers, DNA mismatches, and abasic sites) are known to stimulate topoisomerase I-mediated DNA cleavage. However, the mechanism(s) by which these covalent and noncovalent DNA interactions stimulate topoisomerase I-mediated DNA cleavage remains unclear. Using nogalamycin as a model, we have studied the mechanism of ligand-induced topoisomerase I-mediated DNA cleavage. We show by both mutational and DNA footprinting analyses that the binding of nogalamycin to an upstream site (from position -6 to -3) can induce highly specific topoisomerase I-mediated DNA cleavage. Substitution of this nogalamycin binding site with a DNA bending sequence (A 5) stimulated topoisomerase I-mediated DNA at the same site in the absence of nogalamycin. Replacement of the As sequence with a disrupted DNA bending sequence (A 2-TA 2) significantly reduced the level of topoisomerase I-mediated DNA cleavage. These results, together with the known DNA bending property of nogalamycin, suggest that the nogalamycin-DNA complex may provide a DNA structural bend to stimulate topoisomerase I-mediated DNA cleavage.

原文英語
頁(從 - 到)9928-9934
頁數7
期刊Biochemistry
39
發行號32
DOIs
出版狀態已發佈 - 八月 15 2000
對外發佈Yes

指紋

Nogalamycin
Type I DNA Topoisomerase
DNA Cleavage
Ligands
DNA
coralyne
DNA Mutational Analysis
DNA Footprinting
Dactinomycin
varespladib methyl
Binding Sites

ASJC Scopus subject areas

  • Biochemistry

引用此文

Site-specific topoisomerase I-mediated DNA cleavage induced by nogalamycin : A potential role of ligand-induced DNA bending at a distal site. / Sim, S. P.; Pilch, D. S.; Liu, Leroy-Fong.

於: Biochemistry, 卷 39, 編號 32, 15.08.2000, p. 9928-9934.

研究成果: 雜誌貢獻文章

@article{d4b058a159e048c4b439ae855230cb17,
title = "Site-specific topoisomerase I-mediated DNA cleavage induced by nogalamycin: A potential role of ligand-induced DNA bending at a distal site",
abstract = "Many DNA binding ligands (e.g., nogalamycin, actinomycin D, terbenzimidazoles, indolocarbazoles, nitidine, and coralyne) and various types of DNA lesions (e.g., UV dimers, DNA mismatches, and abasic sites) are known to stimulate topoisomerase I-mediated DNA cleavage. However, the mechanism(s) by which these covalent and noncovalent DNA interactions stimulate topoisomerase I-mediated DNA cleavage remains unclear. Using nogalamycin as a model, we have studied the mechanism of ligand-induced topoisomerase I-mediated DNA cleavage. We show by both mutational and DNA footprinting analyses that the binding of nogalamycin to an upstream site (from position -6 to -3) can induce highly specific topoisomerase I-mediated DNA cleavage. Substitution of this nogalamycin binding site with a DNA bending sequence (A 5) stimulated topoisomerase I-mediated DNA at the same site in the absence of nogalamycin. Replacement of the As sequence with a disrupted DNA bending sequence (A 2-TA 2) significantly reduced the level of topoisomerase I-mediated DNA cleavage. These results, together with the known DNA bending property of nogalamycin, suggest that the nogalamycin-DNA complex may provide a DNA structural bend to stimulate topoisomerase I-mediated DNA cleavage.",
author = "Sim, {S. P.} and Pilch, {D. S.} and Leroy-Fong Liu",
year = "2000",
month = "8",
day = "15",
doi = "10.1021/bi000906h",
language = "English",
volume = "39",
pages = "9928--9934",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "32",

}

TY - JOUR

T1 - Site-specific topoisomerase I-mediated DNA cleavage induced by nogalamycin

T2 - A potential role of ligand-induced DNA bending at a distal site

AU - Sim, S. P.

AU - Pilch, D. S.

AU - Liu, Leroy-Fong

PY - 2000/8/15

Y1 - 2000/8/15

N2 - Many DNA binding ligands (e.g., nogalamycin, actinomycin D, terbenzimidazoles, indolocarbazoles, nitidine, and coralyne) and various types of DNA lesions (e.g., UV dimers, DNA mismatches, and abasic sites) are known to stimulate topoisomerase I-mediated DNA cleavage. However, the mechanism(s) by which these covalent and noncovalent DNA interactions stimulate topoisomerase I-mediated DNA cleavage remains unclear. Using nogalamycin as a model, we have studied the mechanism of ligand-induced topoisomerase I-mediated DNA cleavage. We show by both mutational and DNA footprinting analyses that the binding of nogalamycin to an upstream site (from position -6 to -3) can induce highly specific topoisomerase I-mediated DNA cleavage. Substitution of this nogalamycin binding site with a DNA bending sequence (A 5) stimulated topoisomerase I-mediated DNA at the same site in the absence of nogalamycin. Replacement of the As sequence with a disrupted DNA bending sequence (A 2-TA 2) significantly reduced the level of topoisomerase I-mediated DNA cleavage. These results, together with the known DNA bending property of nogalamycin, suggest that the nogalamycin-DNA complex may provide a DNA structural bend to stimulate topoisomerase I-mediated DNA cleavage.

AB - Many DNA binding ligands (e.g., nogalamycin, actinomycin D, terbenzimidazoles, indolocarbazoles, nitidine, and coralyne) and various types of DNA lesions (e.g., UV dimers, DNA mismatches, and abasic sites) are known to stimulate topoisomerase I-mediated DNA cleavage. However, the mechanism(s) by which these covalent and noncovalent DNA interactions stimulate topoisomerase I-mediated DNA cleavage remains unclear. Using nogalamycin as a model, we have studied the mechanism of ligand-induced topoisomerase I-mediated DNA cleavage. We show by both mutational and DNA footprinting analyses that the binding of nogalamycin to an upstream site (from position -6 to -3) can induce highly specific topoisomerase I-mediated DNA cleavage. Substitution of this nogalamycin binding site with a DNA bending sequence (A 5) stimulated topoisomerase I-mediated DNA at the same site in the absence of nogalamycin. Replacement of the As sequence with a disrupted DNA bending sequence (A 2-TA 2) significantly reduced the level of topoisomerase I-mediated DNA cleavage. These results, together with the known DNA bending property of nogalamycin, suggest that the nogalamycin-DNA complex may provide a DNA structural bend to stimulate topoisomerase I-mediated DNA cleavage.

UR - http://www.scopus.com/inward/record.url?scp=0034663907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034663907&partnerID=8YFLogxK

U2 - 10.1021/bi000906h

DO - 10.1021/bi000906h

M3 - Article

C2 - 10933812

AN - SCOPUS:0034663907

VL - 39

SP - 9928

EP - 9934

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 32

ER -